Enzymotec Ltd (NASDAQ:ENZY)

8.25
Delayed Data
As of Jul 02
 +0.13 / +1.60%
Today’s Change
5.38
Today|||52-Week Range
15.40
+7.98%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close8.12
Today’s open8.10
Day’s range7.85 - 8.35
Volume37,228
Average volume (3 months)37,800
Market cap$186.1M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-76.16%
Earnings growth (this year)-16.91%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-27.51%
P/E ratio--
Price/Sales3.76
Price/Book1.45

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...+0.05+2.62%
FATEFate Therapeutics In...+0.17+2.54%
PSTIPluristem Therapeuti...-0.05-1.99%
CURNeuralstem Inc+0.08+4.28%
Data as of 4:04pm ET, 07/02/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.06
Annual revenue (last year)$47.1M
Annual profit (last year)$7.8M
Net profit margin16.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Vice President-
Operations
Yariv Gratz
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers